Habash Fuad, Vallurupalli Srikanth
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Division of Cardiology, University of Arkansas for Medical Sciences, 4301 West Markham Street, slot 532, Little Rock, AR 72205, USA.
Ther Adv Cardiovasc Dis. 2017 Aug;11(8):203-213. doi: 10.1177/1753944717711139. Epub 2017 Jun 7.
Left ventricular thrombus (LVT) complicates both ischemic and non-ischemic cardiomyopathies and is a potential cause of thromboembolic complications such as stroke. Management of LVT in the 21st century is primarily based on studies before the widespread use of potent pharmacological and interventional therapies such as primary percutaneous coronary intervention, especially in the setting of acute myocardial infarction. Though advances in diagnostic technology have improved detection of LVT, clinicians face several uncertainties in the management of LVT in daily practice. The aim of this paper is to examine several controversies in the diagnosis and management of LVT. Prospective studies are needed to advance therapy of LVT.
左心室血栓（LVT）可使缺血性和非缺血性心肌病复杂化，并且是诸如中风等血栓栓塞并发症的潜在原因。21世纪LVT的管理主要基于在强力药物和介入治疗（如直接经皮冠状动脉介入治疗）广泛应用之前的研究，尤其是在急性心肌梗死的情况下。尽管诊断技术的进步提高了LVT的检测率，但临床医生在日常实践中对LVT的管理仍面临一些不确定性。本文的目的是探讨LVT诊断和管理中的几个争议点。需要进行前瞻性研究以推进LVT的治疗。
